The Unique Constraints of Medical Silicon
Medical device semiconductors operate under constraints that would seem absurd in consumer electronics. A pacemaker's microcontroller needs to run for 10-15 years on a battery the size of a coin. An implantable neural stimulator has to function reliably at 37°C body temperature, surrounded by corrosive saline, with zero tolerance for failure. And every design change, no matter how minor, potentially triggers a regulatory review that can take months.
The FDA classifies medical devices into three classes based on risk. Class I (bandages, tongue depressors) barely involves electronics. Class II (blood pressure monitors, powered wheelchairs) requires a 510(k) premarket notification showing substantial equivalence to an existing device. Class III (pacemakers, cochlear implants, artificial hearts) requires a premarket approval (PMA) with clinical trial data. The chip inside a Class III device is held to standards that make automotive qualification look casual.
Ultra-Low Power: Counting Every Nanoamp
For implantable devices, power consumption isn't just a convenience metric — it directly determines the size of the battery, which determines the size of the implant, which determines where in the body it can be placed and how invasive the surgery is. Every nanoamp matters.
A modern cardiac pacemaker consumes about 10-25 microamps average current, depending on the pacing mode and telemetry usage. The primary cell (typically lithium-iodine or lithium-carbon monofluoride) has a capacity of roughly 1-2 Ah. Simple division gives you the 7-15 year battery life that patients and cardiologists expect.
Achieving this kind of efficiency requires tricks that mainstream chip designers rarely bother with:
We covered a related topic in Memory Interface Design: PHY IP, Signal Integrity, and High-.
- Sub-threshold circuit design — running transistors with gate voltages below Vt, where they operate in the exponential (weak inversion) region. Current is tiny, but so is speed. For a pacemaker that processes a few hundred samples per second, that's fine.
- Aggressive power gating — most of the chip is powered off most of the time. The sensing amplifier wakes up for a few milliseconds each cardiac cycle, processes the signal, makes a pace/no-pace decision, and goes back to sleep.
- Analog front-end optimization — the ECG sensing amplifier in an implantable cardiac monitor might draw 500 nA while achieving noise floors below 1 µVrms. That's extraordinary analog design.
- Custom low-leakage process options — foundries like TSMC and GlobalFoundries offer low-leakage process variants (often designated LL or ULL) with higher threshold voltages that dramatically reduce standby current at the cost of some speed.
Wireless Power and Charging
Some newer implantable devices use rechargeable batteries with wireless power transfer through the skin. Spinal cord stimulators from companies like Medtronic and Boston Scientific use inductive coupling at frequencies around 125 kHz to charge internal lithium-ion cells. The power transfer efficiency through tissue is typically 30-50%, depending on depth and alignment.
The chip design challenge here is the charging management circuit. It needs to handle varying coupling coefficients as the patient moves, prevent overcharging (which is a battery fire risk inside someone's body), and communicate charging status back to the external unit — all while staying within SAR (specific absorption rate) limits that prevent tissue heating.
Biocompatibility and Packaging
The human body is a hostile environment for electronics. Saline fluid is corrosive. The immune system treats foreign objects as invaders. Temperature is constant at 37°C, but humidity is effectively 100%. Standard IC packages would fail within weeks.
Implantable devices use hermetic sealing — typically a titanium enclosure with ceramic-to-metal feedthroughs for electrical connections. The feedthroughs use brazed alumina or sapphire insulators that provide electrical isolation while maintaining a hermetic seal. A well-made feedthrough has a helium leak rate below 10⁻⁸ atm·cc/sec, meaning essentially zero moisture ingress over the device lifetime.
See also: DDR5 vs LPDDR5X: Memory Architecture, Bandwidth, and Power E.
The titanium case itself is biocompatible — the body forms a thin fibrous capsule around it but doesn't actively attack it. Medical-grade titanium (usually Grade 1 or Grade 23) has decades of clinical history in implants.
For some applications, like neural interfaces where the electrodes need direct tissue contact, biocompatible coatings on the chip itself are necessary. Parylene-C is a common conformal coating that provides moisture barrier and biocompatibility. Newer approaches use atomic-layer-deposited alumina or silicon carbide films that can protect the chip for years in the body without the relatively thick layer that Parylene requires.
Sensing and Stimulation ICs
Medical-grade analog front-ends are remarkably sophisticated. A cochlear implant's speech processor has to decompose incoming sound into 12-22 frequency channels, extract the envelope of each, and convert that into a pattern of electrical stimulation pulses delivered to electrodes in the cochlea. All in real time, all on a power budget of a few milliwatts.
Neural recording ICs — used in brain-computer interfaces and research systems — face even tougher specifications. Neural signals are tiny, typically 50-500 µV for local field potentials and 100-500 µV for individual neuron spikes. The recording amplifier needs input-referred noise below 5 µVrms while drawing less than 5 µA per channel. Multiply that by 128 or 256 channels, and power management becomes serious engineering.
See also: Việc Làm Bán Dẫn Việt Nam 2026: Lương & Tuyển Dụng.
Companies like Intan Technologies and Blackrock Microsystems have developed multi-channel neural recording ASICs that achieve these specs. Intan's RHD2164 records from 64 channels simultaneously with 16-bit resolution at 30 kHz sample rate, consuming about 7.5 mW total. That's roughly 115 µW per channel — impressive for the signal quality it delivers.
Regulatory Impact on Chip Design
The FDA's regulatory framework profoundly affects semiconductor choices for medical devices. Once a device is approved, changing the chip — even to a pin-compatible next-generation part — can trigger a new regulatory submission. This creates enormous pressure to use long-lifecycle components.
Medical device companies routinely buy lifetime supplies of critical components when an end-of-life notice arrives. It's not unusual to see a pacemaker design that's been in production for 8-10 years using the same microcontroller throughout, even though three newer generations have been released. The regulatory cost of requalifying with a new chip exceeds the engineering effort of stockpiling the old one.
This is why many medical device companies design their own ASICs rather than relying on commercial off-the-shelf parts. An ASIC's lifecycle is controlled by the company that designed it — you can keep the foundry running your wafers as long as you're willing to pay for mask maintenance. It removes the dependency on a semiconductor vendor's product roadmap decisions.
Emerging Directions
Flexible and stretchable electronics are opening new possibilities for medical sensors. Conformable patches that adhere to the skin and monitor ECG, SpO2, or glucose continuously are already in the market (Dexcom's G7, Abbott's FreeStyle Libre). The semiconductor content is minimal — usually a small rigid chip island on a flexible substrate — but the packaging and interconnect challenges are significant.
The longer-term vision is fully biodegradable electronics: sensors that dissolve safely in the body after their useful life, eliminating the need for a removal surgery. Researchers have demonstrated transistors made from silk, magnesium, and silicon nanomembranes that function for days to weeks before dissolving in physiological fluid. It's still early-stage research, but it's the kind of work that could fundamentally change how we think about medical semiconductor design.